Edition:
United Kingdom

Indoco Remedies Ltd (INRM.NS)

INRM.NS on National Stock Exchange of India

257.65INR
10:14am GMT
Change (% chg)

Rs-1.45 (-0.56%)
Prev Close
Rs259.10
Open
Rs264.95
Day's High
Rs264.95
Day's Low
Rs256.60
Volume
62,318
Avg. Vol
214,669
52-wk High
Rs317.40
52-wk Low
Rs178.10

Chart for

About

Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company's geographical segments include India and Outside India. It offers... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Indoco Remedies Gets European GMP Certification For Manufacturing Facility In Goa

* GOT EUROPEAN GMP CERTIFICATION FROM REGULATORY AUTHORITY OF HUNGARY FOR MANUFACTURING FACILITY OF NON-STERILE PRODUCTS IN GOA Source text: http://bit.ly/2sxPO9u Further company coverage:

15 Feb 2018

BRIEF-India's Indoco Remedies Gets 8 Observations From U.S. FDA

* GETS 8 OBSERVATIONS FROM U.S. FDA AFTER INSPECTION OF CO'S SOLID DOSAGE PLANT IN GOA Source text - http://bit.ly/2HaiQPW Further company coverage:

12 Feb 2018

BRIEF-India's Indoco Remedies Dec-Qtr Profit Rises

* DEC QUARTER PROFIT 226.6 MILLION RUPEES VERSUS PROFIT 175.9 MILLION RUPEES YEAR AGO

25 Jan 2018

BRIEF-Indoco Remedies to start production of existing ophthalmic products from Goa plant II

* Says co to start production of existing ophthalmic products from Goa plant II for U.S. market‍​ Source text - http://bit.ly/2h8Hqol Further company coverage:

07 Nov 2017

BRIEF-India's Indoco Remedies Sept-qtr profit down nearly 11 pct

* Sept quarter profit 197.6 million rupees versus profit of 221.3 million rupees last year

07 Nov 2017

Earnings vs. Estimates

No consensus analysis data available.